Endocannabinoid-dopamine interactions in striatal synaptic plasticity

Frontiers in Pharmacology

Volumn 3 APR, Issue , 2012, Pages

  Mathur, Brian N ^a   Lovinger, David M ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

5 HT1b; Adenosine; CB1; Long term depression; Medium spiny neuron; Parkinson's disease; Serotonin

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ADENOSINE A2 RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ENDOCANNABINOID; LEVODOPA; NITRIC OXIDE; RESERPINE; SEROTONIN AGONIST;

ARTICLE; BRAIN CORTEX; CATALEPSY; CORPUS STRIATUM; DISEASE COURSE; DRUG EFFICACY; DYSKINESIA; ELECTROENCEPHALOGRAM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GABAERGIC SYSTEM; HUMAN; LONG TERM DEPRESSION; NERVE CELL PLASTICITY; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SHORT TERM DEPRESSION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TREATMENT RESPONSE;

EID: 84866170442     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00066     Document Type: Article

References (114)

1. Abdallah, L., Bonasera, S. J., Hopf, F. W., O'Dell, L., Giorgetti, M., Jongsma, M., Carra, S., Pierucci, M., Di Giovanni, G., Esposito, E., Parsons, L. H., Bonci, A., and Tecott, L. H. (2009). Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostri-atal dopamine pathway function. J. Neurosci. 29, 8156-8165.
2. Ade, K. K., and Lovinger, D. M. (2007). Anandamide regulates postnatal development of long-term synaptic plasticity in the rat dor-solateral striatum. J. Neurosci. 27, 2403-2409.
3. Adermark, L., and Lovinger, D. M. (2007). Combined activation of L-type Ca2+ channels and synaptic transmission is sufficient to induce striatal longterm depression. J. Neurosci. 27, 6781-6787.
4. Adermark, L., and Lovinger, D. M. (2009). Frequency-dependent inversion of net striatal output by endocannabinoid-dependent plasticity at different synaptic inputs. J. Neurosci. 29, 1375-1380.
5. Adermark, L., Talani, G., and Lovinger, D. M. (2009). Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur. J. Neurosci. 29, 32-41.
6. Bagetta, V., Picconi, B., Marinucci, S., Sgobio, C., Pendolino, V., Ghiglieri, V., Fusco, F. R., Giampà, C., and Calabresi, P. (2011). Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. J. Neurosci. 31, 12513-12522.
7. Bamford, N. S., Robinson, S., Palmiter, R. D., Joyce, J. A., Moore, C., and Meshul, C. K. (2004a). Dopamine modulates release from corticos-triatal terminals. J. Neurosci. 24, 9541-9552.
8. Bamford, N. S., Zhang, H., Schmitz, Y., Wu, N. P., Cepeda, C., Levine, M. S., Schmauss, C., Zakharenko, S. S., Zablow, L., and Sulzer, D. (2004b). Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42, 653-663.
9. Berke, J. D., and Hyman, S. E. (2000). Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25,515-532.
10. Blomeley, C., and Bracci, E. (2005). Excitatory effects of serotonin on rat striatal cholinergic interneu-rones. J. Physiol .(Lond.) 569, 715-721.
11. Bonsi, P., Cuomo, D., Ding, J., Scia-manna, G., Ulrich, S., Tscherter, A., Bernardi, G., Surmeier, D. J., and Pisani, A. (2007). Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsy-chopharmacology 32,1840-1854.
12. Breese, G. R., Baumeister, A. A., McCown, T. J., Emerick, S. G., Frye, G. D., Crotty, K., and Mueller, R. A. (1984). Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J. Pharmacol. Exp. Ther. 231,343-354.
13. Brenowitz, S. D., and Regehr, W. G. (2005). Associative short-term synaptic plasticity mediated by endocannabinoids. Neuron 45, 419-431.
14. Brown, J. R., and Arbuthnott, G. W. (1983). The electrophysiology of dopamine (D2) receptors: a study of the actions of dopamine on corticostriatal transmission. Neuroscience 10,349-355.
15. Brown, S. J., James, S., Reddington, M., and Richardson, P. J. (1990). Both A1 and A2a purine receptors regulate striatal acetylcholine release. J. Neurochem. 55,31-38.
16. Cadogan, A. K., Alexander,S. P., Boyd,E. A., and Kendall, D. A. (1997). Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. J. Neurochem. 69, 1131-1137.
17. Calabresi, P., Centonze, D., Gubellini, P., Marfia, G. A., and Bernardi, G. (1999). Glutamate-triggered events inducing corticostriatal long-term depression. J. Neurosci. 19,6102-6110.
18. Calabresi, P., Maj, R., Pisani, A., Mercuri, N.B., and Bernardi, G. (1992). Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J. Neurosci. 12,4224-4233.
19. Calabresi, P., Saiardi, A., Pisani, A., Baik, J. H., Centonze, D., Mercuri, N. B., Bernardi, G., and Borrelli, E. (1997). Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J. Neurosci. 17, 4536-4544.
20. Carta, M., Carlsson, T., Kirik, D., and Björklund, A. (2007). Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskine-sia in parkinsonian rats. Brain 130, 1819-1833.
21. Centonze, D., Battista, N., Rossi, S., Mercuri, N. B., Finazzi-Agrò, A., Bernardi, G., Calabresi, P., and Mac-carrone, M. A. (2004) A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic transmission. Neuropsy-chopharmacology 29, 1488-1497.
22. Centonze, D., Grande, C., Saulle, E., Martin, A. B., Gubellini, P., Pavón, N., Pisani, A., Bernardi, G., Moratalla, R., and Calabresi, P. (2003). Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. J. Neurosci. 23, 8506-8512.
23. Chen, J. J., and Swope, D. M. (2007). Pharmacotherapy for Parkinson's disease. Pharmacotherapy 27, 161S-173S.
24. Choi, S., and Lovinger, D. M. (1997a). Decreased probability of neuro-transmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses. Proc. Natl. Acad. Sci. U.S.A. 94,2665-2670.
25. Choi, S., and Lovinger, D. M. (1997b). Decreased frequency but not amplitude of quantal synaptic responses associated with expression of corticostriatal long-term depression. J. Neurosci. 17, 8613-8620.
26. Crittenden, J. R., and Graybiel, A. M. (2011). Basal ganglia disorders associated with imbalances in the striatal striosome and matrix compartments. Front. Neuroanat. 5:59. doi:10.3389/fnana.2011.00059
27. Day, M., Wang, Z., Ding, J., An, X., Ing-ham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., Mugnaini,E.,Deutch,A.Y.,Sesack, S. R., Arbuthnott, G. W., and Surmeier, D. J. (2006). Selective elimination of glutamatergic synapses on stri-atopallidal neurons in Parkinson disease models. Nat. Neurosci. 9, 251-259.
28. Deutch, A. Y., Colbran, R. J., and Winder, D. J. (2007). Striatal plasticity and medium spiny neuron dendritic remodeling in parkinson-ism. Parkinsonism Relat. Disord. 13, S251-S258.
29. Devane, W. A, Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A, Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
30. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J. C., and Piomelli, D. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691.
31. Doreulee, N., Sergeeva, O. A., Yanovsky, Y., Chepkova, A. N., Selbach, O., Gödecke, A., Schrader, J., and Haas, H. L. (2003). Cortico-striatal synap-tic plasticity in endothelial nitric oxide synthase deficient mice. Brain Res. 964, 159-163.
32. Erinoff, L., MacPhail, R. C., Heller, A., and Seiden, L. S. (1979). Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat. Brain Res. 164, 195-205.
33. Flores-Hernández, J., Galarraga, E., and Bargas, J. (1997). Dopamine selects glutamatergic inputs to neostriatal neurons. Synapse 25,185-195.
34. Freiman, I., Anton, A., Monyer, H., Urbanski, M. J., and Szabo, B. (2006). Analysis of the effects of cannabinoids on identified synap-tic connections in the caudate-putamen by paired recordings in transgenic mice. J. Physiol. (Lond.) 575, 789-806.
35. Gerdeman, G., and Lovinger, D. M. (2001). CB1cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol. 85,468-471.
36. Gerdeman, G. L., Ronesi, J., and Lovinger, D. M. (2002). Postsynaptic endocannabinoid release is critical to longterm depression in the striatum. Nat. Neurosci. 5, 446-451.
37. Gough, A. L., and Olley, J. E. (1978). Catalepsy induced by intrastriatal injections of delta9-THC and 11-OH-delta9-THC in the rat. Neu-ropharmacology 17, 137-144.
38. Gubellini, P., Saulle, E., Centonze, D., Bonsi, P., Pisani, A., Bernardi, G., Conquet,F.,and Calabresi,P. (2001). Selective involvement of mGlu1 receptors in corticostriatal LTD. Neuropharmacology 40, 839-846.
39. Heifets, B. D., and Castillo, P. E. (2009). Endocannabinoid signaling and long-term synaptic plasticity. Annu. Rev. Physiol. 71, 283-306.
40. Heifets, B. D., Chevaleyre, V., and Castillo, P. E. (2008). Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin. Proc. Natl. Acad. Sci. U.S.A. 105, 10250-10255.
41. Hilário, M. R., Clouse, E., Yin, H. H., and Costa, R. M. (2007). Endocannabinoid signaling is critical for habit formation. Front. Integr. Neurosci. 1:6. doi: 10.3389/neuro.07/006.2007
42. Howlett, A. C., and Fleming, R. M. (1984). Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol. 26, 532-538.
43. Howlett, A. C., Qualy, J. M., and Khacha-trian, L. L. (1986). Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29, 307-313.
44. Hsu, K. S., Huang, C. C., Yang, C. H., and Gean, P. W. (1995). Presynaptic D2 dopaminergic receptors mediate inhibition of excitatory synaptic transmission in rat neostriatum. Brain Res. 690, 264-268.
45. Huang, C. C., Lo, S. W., and Hsu, K. S. (2001). Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J. Physiol. (Lond.) 532, 731-748.
46. Huot, P., and Brotchie, J. M. (2011). 5-HT(1A) receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: bridging the gap between serotonergic and glutamatergic mechanisms. Exp. Neurol. 231, 195-198.
47. Ingham, C. A., Hood, S.H.,and Arbuth-nott, G. W. (1989). Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age. Brain Res. 503, 334-338.
48. Ishac, E. J., Jiang, L., Lake, K. D., Varga, K., Abood, M. E., and Kunos, G. (1996). Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol. 118,2023-2028.
49. James, S., and Richardson, P. J. (1993). The subcellular distribution of [3H]-CGS 21680 binding sites in the rat striatum: copurification with cholinergic nerve terminals. Neu-rochem. Int. 23,115-122.
50. Jin, W., Brown, S., Roche, J. P., Hsieh, C., Celver, J. P., Kovoor, A., Chavkin, C., and Mackie, K. (1999). Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J. Neurosci. 19, 3773-3780.
51. Jin, X., and Costa, R. M. (2010). Start/stop signals emerge in nigros-triatal circuits during sequence learning. Nature 466, 457-462.
52. Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., and Watanabe, M. (2009). Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 89, 309-380.
53. Kathmann, M., Bauer, U., Schlicker, E., and Göthert, M. (1999). Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Naunyn Schmiedebergs Arch. Pharmacol. 359, 466-470.
54. Katona, I., Sperlágh, B., Sík, A., Käfalvi, A., Vizi, E. S., Mackie, K., and Fre-und, T. F. (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocam-pal interneurons. J. Neurosci. 19, 4544-4558.
55. Kheirbek, M. A., Britt, J. P., Beeler, J. A., Ishikawa, Y., McGehee, D. S., and Zhuang, X. (2009). Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning. J. Neurosci. 29, 12115-12124.
56. Klapstein, G. J., Fisher, R. S., Zanjani, H., Cepeda, C., Jokel, E. S., Chesse-let, M. F., and Levine, M. S. (2001). Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J. Neurophysiol. 86, 2667-2677.
57. Kreitzer, A. C., and Malenka, R. C. (2005). Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J. Neurosci. 25, 10537-10545.
58. Kreitzer, A. C., and Malenka, R. C. (2007). Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 445, 643-647.
59. Kreitzer, A. C., and Malenka, R. C. (2008). Striatal plasticity and basal ganglia circuit function. Neuron 60, 543-554.
60. Lee, S. P., So, C. H., Rashid, A. J., Varghese, G., Cheng, R., Lança, A. J., O'Dowd, B. F., and George, S. R. (2004). Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J. Biol. Chem. 279, 35671-35678.
61. Lerner, T. N., and Kreitzer, A. C. (2012). RGS4 is required for dopaminergic control of striatal LTD and susceptibility to Parkinsonian motor deficits. Neuron 73, 347-359.
62. Liu, J., Wang, L., Harvey-White, J., Huang, B. X., Kim, H. Y., Luquet, S., Palmiter, R. D., Krystal, G., Rai, R., Mahadevan, A., Razdan, R. K., and Kunos, G. (2008). Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology 54, 1-7.
63. Lovinger, D. M. (2008). Presynaptic modulation by endocannabi-noids. Handb. Exp. Pharmacol. 184, 435-477.
64. Lovinger, D. M., Partridge, J. G., and Tang, K. C. (2003). Plastic control of striatal glutamatergic transmission by ensemble actions of several neu-rotransmitters and targets for drugs of abuse. Ann. N Y. Acad. Sci. 1003, 226-240.
65. Lovinger, D. M., Tyler, E. C., and Mer-ritt, A. (1993). Short- and long-term synaptic depression in rat neostriatum. J. Neurophysiol. 70, 1937-1949.
66. Luthman, J., Fredriksson, A., Sundström, E., Jonsson, G., and Archer, T. (1989). Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage. Behav. Brain Res. 33, 267-277.
67. Malenka, R. C., and Bear, M. F. (2004). LTP and LTD: an embarrassment of riches. Neuron 44, 5-21.
68. Marsicano, G., and Lutz, B. (1999). Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11, 4213-4225.
69. Martire, A., Tebano, M. T., Chiodi, V., Ferreira, S. G., Cunha, R. A., Köfalvi, A., and Popoli, P. (2011). Presynaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission. J. Neurochem. 116,273-280.
70. Mathur, B. N., Capik, N. A., Alvarez, V. A., and Lovinger, D. M. (2011). Serotonin induces long-term depression at corticostriatal synapses. J. Neurosci. 31,7402-7411.
71. Mato, S., Lafourcade, M., Robbe, D., Bakiri,Y.,and Manzoni, O. J. (2008). Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca + + channels in endocannabinoid-mediated long-term depression in the nucleus accumbens. Neuropharmacology 54, 87-94.
72. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., and Bonner, T. I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
73. Mátyás, F., Yanovsky, Y., Mackie, K., Kelsch, W., Misgeld, U., and Freund, T. F. (2006). Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience 137,337-361.
74. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., Per-twee, R. G., Griffin, G., Bayewitch, M., Barg, J., and Vogel, Z. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
75. Narushima, M., Hashimoto, K., and Kano, M. (2006a). Endocannabinoid-mediated shortterm suppression of excitatory synaptic transmission to medium spiny neurons in the striatum. Neurosci. Res. 54, 159-164.
76. Narushima, M., Uchigashima, M., Hashimoto, K., Watanabe, M., and Kano, M. (2006b). Depolarization-induced suppression of inhibition mediated by endocannabinoids at synapses from fast-spiking interneu-rons to medium spiny neurons in the striatum. Eur. J. Neurosci. 24, 2246-2252.
77. Narushima, M., Uchigashima, M., Fukaya, M., Matsui, M., Manabe, T., Hashimoto, K., Watanabe, M., and Kano, M. (2007). Tonic enhancement of endocannabinoid-mediated retrograde suppression of inhibition by cholinergic interneuron activity in the striatum. J. Neurosci. 27, 496-506.
78. Ondracek, J. M., Dec, A., Hoque, K. E., Lim, S. A., Rasouli, G., Indorkar, R. P., Linardakis, J., Klika, B., Mukherji, S. J., Burnazi, M., Threlfell, S., Sam-mut, S., and West, A. R. (2008). Feedforward excitation of striatal neuron activity by frontal cortical activation of nitric oxide signaling in vivo. Eur. I Neurosci. 27, 1739-1754.
79. Peterson, J. D., Goldberg, J. A., and Surmeier, D. J. (2012). Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion. Neurobiol. Dis. 45,409-416.
80. Picconi, B., Bagetta, V., Ghiglieri, V., Paillè, V., Di Filippo, M., Pendolino, V., Tozzi, A., Giampà, C., Fusco,F. R., Sgobio, C., and Calabresi, P. (2011). Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. Brain 134, 375-387.
81. Pollack, A. (2004). Coactivation of D1 and D2 dopamine receptors: in marriage, a case of his, hers, and theirs. Sci. STKE 255, 50.
82. Quiroz, C., Luján, R., Uchigashima, M., Simoes, A. P., Lerner, T. N., Borycz, J., Kachroo, A., Canas, P. M., Orru, M., Schwarzschild, M. A., Rosin, D. L., Kreitzer, A. C., Cunha, R. A., Watanabe, M., and Ferré, S. (2009). Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway. Scientific World Journal 9,1321-1344.
83. Robbe, D., Kopf, M., Remaury, A., Bockaert, J., and Manzoni, O. J. (2002). Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A. 99, 8384-8388.
84. Rodriguez, J. J., Mackie, K., and Pickel, V. M. (2001). Ultrastructural localization of the CB1 cannabinoid receptor in muopioid receptor patches of the rat caudate putamen nucleus. J. Neurosci. 21,823-833.
85. Ronesi, J., and Lovinger, D. M. (2005). Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. J. Physiol. 562, 245-256.
86. Rylander, D., Parent, M., O'Sullivan, S. S., Dovero, S., Lees, A. J., Bezard, E., Descarries, L., and Cenci, M. A. (2010). Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann. Neurol. 68, 619-628.
87. Schuman, E. M., and Madison, D. V. (1991). A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254, 1503-1506.
88. Sergeeva, O. A., Doreulee, N., Chepkova, A. N., Kazmierczak, T., and Haas, H. L. (2007). Long-term depression of cortico-striatal synaptic transmission by DHPG depends on endocannabinoid release and nitric oxide synthesis. Eur. J. Neurosci. 26, 1889-1894.
89. Shaywitz, B. A., Yager, R. D., and Klop-per, J. H. (1976). Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191, 305-308.
90. Shen, W., Flajolet, M., Greengard, P., and Surmeier, D. J. (2008). Dichotomous dopaminergic control of striatal synaptic plasticity. Science 321, 848-851.
91. Shimo, Y., and Hikosaka, O. (2001). Role of tonically active neurons in primate caudate in reward-oriented saccadic eye movement. J. Neurosci. 21,7804-7814.
92. Sidló, Z., Reggio, P. H., and Rice, M. E. (2008). Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels. Neurochem. Int. 52, 80-88.
93. Smart, D., Gunthorpe, M. J., Jerman, J. C., Nasir, S., Gray, J., Muir, A. I., Chambers, J. K., Randall, A. D., and Davis, J. B. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 129,227-230.
94. Song, W J., Tkatch, T., and Surmeier, D. J. (2000). Adenosine receptor expression and modulation of Ca(2+) channels in rat striatal cholinergic interneurons. J. Neuro-physiol. 83, 322-332.
95. Stachowiak, M. K., Bruno, J. P., Sny-der, A. M., Stricker, E. M., and Zigmond, M. J. (1984). Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res.291, 164-167.
96. Szabo, B., Dörner, L., Pfreundtner, C, Norenberg, W., and Starke, K. (1998). Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85, 395-403.
97. Tang, K., Low, M. J., Grandy, D. K., and Lovinger, D. M. (2001). Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc. Natl Acad. Sci. U.S.A. 98, 1255-1260.
98. Tozzi, A., de Iure, A., Di Filippo, M., Tantucci, M., Costa, C., Borsini, F., Ghiglieri, V., Giampà, C., Fusco, F. R., Picconi, B., and Calabresi, P. (2011). The distinct role of medium spiny neurons and cholinergic interneurons in the D/AA receptor interaction in the striatum: implications for Parkinson's disease. J. Neurosci. 31, 1850-1862.
99. Tozzi, A., Tscherter, A., Belcastro, V., Tantucci, M., Costa, C., Picconi, B., Centonze, D., Calabresi, P., and Borsini, F. (2007). Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission. Neu-ropharmacology 53, 783-789.
100. Uchigashima, M., Narushima, M., Fukaya, M., Katona, I., Kano, M., and Watanabe, M. (2007). Subcellu-lar arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci. 27, 3663-3676.
101. Varma, N., Carlson, G. C., Ledent, C., and Alger, B. E. (2001). Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J. Neurosci. 21, 188.
102. Wallman, M. J., Gagnon, D., and Parent, M. (2011). Serotonin innervation of human basal ganglia. Eur. J. Neurosci. 33, 1519-1532.
103. Walsh, J. P. (1993). Depression of excitatory synaptic input in rat striatal neurons. Brain Res. 608, 123-128.
104. Wang, Z., Kai, L., Day, M., Ronesi, J., Yin, H. H., Ding, J., Tkatch, T., Lovinger, D. M., and Surmeier, D. J. (2006). Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50, 443-452.
105. Welch, J. M., Lu, J., Rodriguiz, R. M., Trotta, N. C., Peca, J., Ding, J. D., Feliciano, C., Chen, M., Adams, J. P., Luo, J., Dudek, S. M., Weinberg, R. J., Calakos, N.,Wetsel,W C, and Feng, G. (2007). Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 448, 894-900.
106. West, A. R., and Grace, A. A. (2004). The nitric oxideguanylyl cyclase signaling pathway modulates membrane activity States and electrophysiological properties of striatal medium spiny neurons recorded in vivo. J. Neurosci. 24, 1924-1935.
107. Wilson, R. I., and Nicoll, R. A. (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410, 588-592.
108. Xiang, Z., Thompson, A. D., Jones, C. K., Lindsley, C. W., and Conn, P. J. (2012). Roles of the m1 mus-carinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease. J. Pharmacol Exp. Ther. 340, 595-603.
109. Yin, H. H., Adermark, L., and Lovinger, D. M. (2008). Neurotensin reduces glutamatergic transmission in the dorsolateral striatum via retrograde endocannabinoid signaling. Neuropharmacology 54, 79-86.
110. Yin, H. H., and Lovinger, D. M. (2006). Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc. Natl Acad. Sci. U.S.A. 103,8251-8256.
111. Yu, C., Gupta, J., Chen, J. F., and Yin, H. H. (2009). Genetic deletion of A2A adenosine receptors in the striatum selectively impairs habit formation. J. Neurosci. 29, 15100-151003.
112. Zaja-Milatovic, S., Milatovic, D., Schantz, A. M., Zhang, J., Montine, K. S., Samii, A., Deutch, A. Y., and Montine, T. J. (2005). Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 64, 545-547.
113. Zorumski, C. F., and Izumi, Y. (1993). Nitric oxide and hippocam-pal synaptic plasticity. Biochem. Pharmacol. 46, 777-785.
114. Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H., Sørgård,M., Di Marzo, V., Julius, D., and Högestätt, E. D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anan-damide. Nature 400,452-457.